1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

CT - 1025

Where Are the Trials? Geographic Imbalances in CAR-T Cell Therapy Access for Lymphoma

Kristian Simonyan

Poster Presenter: Kristian Simonyan

Thumbnail for Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

CLL - 1026

Comparative Analysis of Long-Term Survival between Black and White Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Post-BTKi era using Real-World Data

Chinenye Okafor

Poster Presenter: Chinenye Okafor

Thumbnail for Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

AML - 1029

Transplant Outcomes and Rates of Graft-Versus-Host Disease for FLT3-ITD Acute Myeloid Leukemia by Graft Source in the Era of Posttransplant Gilteritinib Maintenance

Joseph Mort

Poster Presenter: Joseph Mort

Thumbnail for Projections of Increasing Sex, Geographic, and Age-Based Mortality Disparities in Burkitt Tumor: A Centers for Disease Control and Prevention WONDER Database Analysis Through 2035

ABCL - 1030

Projections of Increasing Sex, Geographic, and Age-Based Mortality Disparities in Burkitt Tumor: A Centers for Disease Control and Prevention WONDER Database Analysis Through 2035

Muhammad Ali Lak

Poster Presenter: Muhammad Ali Lak

Thumbnail for Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

MM - 1031

Real-World Outcomes of Primary and Secondary Plasma Cell Leukemia in the Era of CAR-T and Bispecific Antibody Therapy: A Single-Center Experience

Abat Khan

Poster Presenter: Abat Khan

AML - 1032

Comparative Inpatient Mortality and Hospitalization Burden in AML, ALL, and DLBCL: A Nationwide Analysis, 2016-2020

Srijani Thannir

Poster Presenter: Srijani Thannir

$Thumbnail for Efficacy and Safety of Chimeric Antigen Receptor T-cell (CAR-T) Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis$

MM - 1033

Efficacy and Safety of Chimeric Antigen Receptor T-cell (CAR-T) Therapy Against Standard Regimen in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis

Maryam Maqsood

Poster Presenter: Maryam Maqsood

MDS - 1034

Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms

Akram Abushamma

Poster Presenter: Akram Abushamma

Thumbnail for Comparative Immune and Organ-Specific Toxicity Signals of Brentuximab Vedotin Versus PD-1 Inhibitors in Classical Hodgkin Lymphoma: A FAERS Pharmacovigilance Analysis

HL - 1035

Comparative Immune and Organ-Specific Toxicity Signals of Brentuximab Vedotin Versus PD-1 Inhibitors in Classical Hodgkin Lymphoma: A FAERS Pharmacovigilance Analysis

Farzeen Fatma Syed

Poster Presenter: Farzeen Fatma Syed